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Entamoeba histolytica infects 50 million people worldwide and causes 55 thousand fatalities every year. Current
anti-amebic drugs (e.g. paromomycin) work either at the level of the intestinal lumen (where trophozoites proliferate via cell divisions) or on the invasive trophozoites that have penetrated the gut or colonized internal organs
(e.g. metronidazole). Some of these drugs are highly toxic to patients, have generated trophozoite resistance, or
caused mutations and cancer in laboratory animals. Thus, alternative anti-amebic compounds need to be identiﬁed to minimize the side effects (on patients) or resistance (by amebas) to current treatments. The literature
suggests that anthraquinones (chemicals found in medicinal plants) have antibacterial, antiparasitic, antiinﬂammatory and antioxidant properties. Here we provide experimental evidence that Chinese rhubarb (Rheum
palmatum) leaves' extract (rich in the anthraquinone rhein) inhibits E. histolytica trophozoite growth in vitro. In
addition, from a set of ten isolated/synthetic anthraquinones (which we suspected to have anti-amebic properties), four analogs (rhein; AHHDAC ¼ 1-amino-4-hydroxy-9, 10-dioxo-9, 10-dihydro-anthracene-2-carboxylic
acid; unisol blue AS; and sennoside B) efﬁciently inhibited amebic growth at EIC50 concentrations comparable
to metronidazole. The mechanism of action of these compounds still needs to be determined, although anthraquinones might enhance the production of toxic oxygen metabolites as it has been suggested for various protists
(e.g. Leishmania, Plasmodium, Trypanosoma). Our research is the ﬁrst to explore anti-amebic effects of Chinese
rhubarb leaves' extract and isolated/synthetic anthraquinones on pathogenic Entamoeba.

1. Introduction
Entamoeba histolytica infects 50 million people worldwide and causes
55 thousand fatalities every year [1, 2]. This protist's life cycle consists of
the infectious trophozoite stage and the transmissible cyst stage. Cysts
are ingested with contaminated food or water. Despite the epidemiological importance of E. histolytica, there are no ideal methods to prevent
infection in areas without appropriate sanitation [1, 3]. The development
of a vaccine for amebiasis remains in early stages, although some progress has been made at identifying potential immunogenic proteins and
their effectiveness in animal models [4, 5, 6]. Current anti-amebic drugs
seem to work either at the level of the intestinal lumen, where trophozoites proliferate via cell divisions (e.g. paromomycin, iodoquinol and
diloxanide furoate [7, 8]) or at the level of the intestine's endothelium or
tissue abscesses, on the invasive trophozoites that have already

penetrated the gut or colonized internal organs (e.g. metronidazole,
tinidazole and ornidazole, broadly called nitroimidazoles), but not at
both levels [7, 8, 9]. These drugs, however, are highly toxic to patients
(causing nausea, vomiting, headaches, dizziness, vertigo, neuronal
damage) [7], have generated resistance in E. histolytica [10], or triggered
DNA mutations and cancer in laboratory rodents [11, 12, 13]. Thus,
alternative anti-amebic compounds need to be identiﬁed to minimize the
side effects (on patients) or resistance (by amebas) to current treatments.
More than 50% of FDA-approved drugs are natural products or their
derivatives [14, 15]. Anthraquinones found in medicinal plants (e.g.
Rheum, Hemerocallis, Aloe) have antibacterial, antiparasitic,
anti-inﬂammatory, antioxidant and antitumorigenic properties [16, 17,
18, 19, 20]. Here we show that Chinese rhubarb (Rheum palmatum)
leaves' extract and four isolated/synthetic anthraquinones inhibit
E. histolytica trophozoite growth in the laboratory. We compare the
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Table 1. Anti-amebic effects of Chinese rhubarb (Rheum palmatum) leaves' extract (i.e. "rhein extract" in Figures 1 and 3).
Compound

No. amebas x103

% inhibition

ED50

at 24 h

No. amebas x103

% inhibition

ED50

at 48 h

"rhein extract" 100 μg/ml

0.97

78.52

42.96

0.63

90.31

19.39

metronidazole 20 μM

0.60

86.67

5.33

0.60

90.82

3.67

TYI-S-33 media

4.13

NA

NA

7.67

NA

NA

TYI-S-33 media þ DMSO

4.50

NA

NA

6.53

NA

NA

μg/ml ¼ micrograms per milliliter; μM ¼ micromolar; DMSO ¼ dimethyl sulfoxide. Initial trophozoite inoculum 900 cells at 0h. ED50 ¼ estimated concentration of plant
extract required to inhibit at least 50% of trophozoites in comparison with the control.

Figure 1. Experimental design: tests with Chinese rhubarb (Rheum palmatum) extract (“rhein extract”) or with isolated/synthetic anthraquinones. Top: Extract obtained from Chinese rhubarb leaves was added to suspensions of Entamoeba histolytica trophozoites and incubated for 24h or 48 h at 37  C; likewise, metronidazole (20
μM), TYI-S-33 media or TYI-S-33 media þ DMSO (dimethyl sulfoxide) were added to separate suspensions (both controls); each series was done in triplicate (x3, total
24 wells). Bottom: From commercially available isolated/synthetic anthraquinones (rationale in Methods), four analogs (rhein; AHDDAC ¼ 1-amino-4-hydroxy-9, 10dioxo-9, 10-dihydro-anthracene-2-carboxylic acid; unisol blue AS; or sennoside B; structures in Figure 2) were added (concentrations 60 μM or 120 μM) to the
suspensions of trophozoites and incubated for 24h or 48 h at 37  C; metronidazole, TYI-S-33 media or TYI-S-33 media þ DMSO were separately added as in above;
each series was done in triplicate (x3, total 84 wells). Illustration of R. palmatum comes from Edward Hamilton 1853 [28].

which we suspected could inhibit amebic growth, for additional testing,
as follows: AHDDAC (1-amino-4-hydroxy-9, 10-dioxo-9, 10-dihydro-anthracene-2-carboxylic acid); unisol blue AS; anthraquinone-2-carboxylic
acid; 2,3-bis-bromomethyl-1, 4-dihydroxy-anthraquinone; and quinalizarin (these ﬁve were purchased from Sigma Aldrich, St. Louis, MO); as
well as rhein, sennoside B, diacetyl rhein, sennoside A, and carminic acid
(these ﬁve were purchased from CromaDex, Irvine, CA). All compounds
were stored in dimethyl sulfoxide (DMSO) at -20  C prior to inhibition
assays (below).

inhibition levels of the leaves' extract and isolated/synthetic anthraquinone analogs to those of metronidazole.
2. Materials and methods
2.1. Selection of extracts and isolated/synthetic anthraquinone compounds
for testing
Based on antimicrobial and antiparasitic properties reported in the
literature for Rheum spp. [16, 17, 18, 19, 20], we tested the Chinese
rhubarb “rhein extract” (from leaves) for potential anti-amebic effects. A
commercial powder containing >90% rhein, “rhein extract”, was purchased from Natural-Field Bio-Technique Co. (Xi'an, China). Relying on
the chemical structure of rhein (i.e. the anthraquinone present in
R. palmatum [17, 18] and main component of the commercial “rhein
extract”), we selected ten isolated/synthetic anthraquinone analogs,

2.2. Amebas' cell-line cultures and inhibition assays
Entamoeba histolytica HM-1:1MSS trophozoites were cultured under
axenic conditions in Diamond's TYI-S-33 medium plus 10% ABS at 37  C
as described previously [21, 22, 23, 24]. To assess inhibition of
E. histolytica growth, by either “rhein extract” or the ten
2
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Table 2. Anti-amebic effects of isolated/synthetic anthraquinones: rhein, AHDDAC, unisol blue AS, or sennoside B (as in Figure 2).
Compound

No. amebas x103

No. amebas x103

% inhibition

at 24 h

% inhibition

IC50

at 48 h

rhein 20 μM

5.5

15.82

4.20

48.78

‒

rhein 40 μM

2.23

65.87

2.30

71.95

‒

rhein 60 μM

0.90

86.22

1.7

86.99

‒

rhein 120 μM

0.37

94.39

0.37

95.53

‒

IC50 rhein μM

‒

‒

‒

‒

20.74

AHDDAC 20 μM

5.90

9.69

5.87

28.41

‒

AHDDAC 40 μM

3.52

46.12

3.79

53.78

‒

AHDDAC 60 μM

1.27

80.61

1.37

83.33

‒

AHDDAC 120 μM

0.97

85.20

0.77

90.65

‒

IC50 AHDDAC μM

‒

‒

‒

‒

36.07

unisol blue AS 20 μM

6.52

0.20

1.83

28.05

‒

unisol blue AS 40 μM

3.80

41.84

1.27

57.39

‒

unisol blue AS 60 μM

2.17

66.84

1.83

77.64

‒

unisol blue AS 120 μM

1.67

74.49

1.27

84.55

‒

IC50 unisol blue AS μM

‒

‒

‒

‒

33.59

sennoside B 20 μM

6.50

0.51

5.50

32.93

‒

sennoside B 40 μM

3.20

51.02

3.10

62.20

‒

sennoside B 60 μM

1.53

76.53

1.33

83.74

‒

sennoside B 120 μM

0.63

90.31

0.63

92.28

‒

IC50 sennoside B μM

‒

‒

‒

‒

29.96

metronidazole 1 μM

4.20

35.71

5.90

28.05

‒

metronidazole 5 μM

1.90

70.92

2.30

71.95

‒

metronidazole 10 μM

0.80

87.76

1.10

86.59

‒

metronidazole 20 μM

0.50

92.35

0.30

96.34

‒

IC50 metronidazole μM

‒

‒

‒

‒

3.16

TYI-S-33 media

6.17

NA

9.20

NA

NA

TYI-S-33 media þ DMSO

6.53

NA

8.20

NA

NA

μM ¼ micromolar; DMSO ¼ dimethyl sulfoxide. Initial trophozoite inoculum 900 cells at 0h. IC50 ¼ concentration of compounds required to inhibit 50% of trophozoites
after 48h. AHDDAC ¼ 1-amino-4-hydroxy-9,10-dioxo-9,10-dihydro-anthracene-2-carboxylic acid.

above (controls). Each series was done in triplicate (total 84 wells;
experimental design for isolated/synthetic anthraquinones is depicted in
Figure 1 bottom) during three independent experiments. To calculate the
IC50 (¼ the concentration of compound required to inhibit 50% of trophozoites after 48h, Table 2), we used the formula IC50 ¼ 10log(A/B)
x(50–C)/(D–C)þLog(B)
, where A is the concentration of test compound
directly above 50% inhibition, B is the concentration of test compound
directly below 50% inhibition, C is the percentage of inhibition directly
below 50% inhibition, and D is the percentage of inhibition directly
above 50% inhibition [27].
Out of the ten compounds, four inhibited amebic growth: rhein,
AHDDAC, unisol blue AS, or sennoside B (structures in Figure 2). Below
we only discuss these four compounds (all other data available from
authors).

isolated/synthetic anthraquinones (above), we designed two sets of experiments. First, ﬂat-bottomed 24-well plates (Fisher Scientiﬁc, Pittsburg, PA) containing an initial inoculation of 900 trophozoites per well
(log phase) were grown for 24 h or 48 h in TYI-S-33 media (i.e. “amebas
in TYI-S-33 media”), or supplemented with Chinese rhubarb leaves'
extract (“rhein extract”) at 100 μg/ml concentration dissolved in DMSO.
A similar volume of DMSO was added to wells with ameba (i.e. “amebas
in TYI-S-33 media þ DMSO”) to control for potential solvent toxicity [22,
23, 24, 25, 26]. Metronidazole (market drug of choice to treat amebiasis)
at 20 μM concentration was used as a positive control of inhibition. The
24-well plates were sealed with paraﬁlm to minimize the exposure to
oxygen. The estimated concentration of plant extract required to inhibit
at least 50% of trophozoites in comparison with the control (Table 1) was
determined by the following formula: ED50 ¼ [(A/B) * drug concentration μg/ml]/0.5; where A ¼ mean value of trophozoites counted on plant
extract treated wells at the end of each incubation period (e.g. 24 h/48 h)
and B ¼ mean value of trophozoites counted on media control wells at the
end of each incubation period (24 h/48 h) [20, 22]. The experiments
were done in triplicate (total 24 wells; experimental design for “rhein
extract” is depicted in Figure 1 top) during three independent experiments. Counts of viable ameba cells were estimated with a Cellometer
Vision HS RF-150 (Nexcelom BioScience Lawrence, MA) as detailed
previously [22, 23, 24, 25, 26]. Second, all ten isolated/synthetic anthraquinones were dissolved in DMSO (as in above), added to the suspensions of trophozoites at concentrations of 60 μM or 120 μM, and
incubated for 24 h or 48 h at 37  C. Metronidazole, TYI-S-33 media or
TYI-S-33 media þ DMSO were separately added to the trophozoites as in

3. Results
Chinese rhubarb R. palmatum “rhein extract” (from leaves) inhibited
E. histolytica HM-1:1MSS trophozoite growth at 24 h and 48 h at 100 μg/
ml concentration, and differed from the controls TYI-S-33 media or TYIS-33 media þ DMSO (Figure 3). “Rhein extract” showed noticeably
higher percentage of growth inhibition and lower ED50 values at 48 h
(90.31%,19.39 μM; Table 1) than at 24 h (78.52%, 42.96 μM; Table 1).
The rate of “rhein extract” inhibition was roughly comparable to that of
metronidazole at 24 h or 48 h (Table 1). ED50 was, of course, much lower
for metronidazole than for “rhein extract” at both times (Table 1), which
was expected for a puriﬁed commercial drug.
3
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Figure 2. Isolated/synthetic anthraquinone analogs with anti-amebic properties. When E. histolytica trophozoites were exposed to these four anthraquinones (rhein or
its derivatives AHDDAC ¼ 1-amino-4-hydroxy-9,10-dioxo-9,10-dihydro-anthracene-2-carboxylic acid; unisol blue AS; or sennoside B), amebic growth was inhibited at
EIC50 concentrations comparable to the anti-amebic drug metronidazole, as shown in Figure 4 (structures generated by Hang Ma).

Although some anthraquinones can be toxic to humans, rhein and
derivatives seem to have little to no toxicity, even at mg levels, when
added to food [29]. A review published by the European Food Safety
Authority (EFSA, 2018) states that after evaluating in vitro and in vivo
studies on hydroxyanthracene derivatives, rhein and sennoside B showed
no genotoxic effects at 78.8 mg- and 24. 84 mg-/adult/day, respectively
[29]. Baqui et al. 2009 showed that the anthraquinone scaffold (1-amino-4-anilino-9,10-dioxo-9,10-dihydroanthracene-2-sulfonate) showed
preferential cytotoxicity for cancerous compared to non-cancerous cells
[30]. Due to the low IC50 values reported in this study (20.74–36.07 μM),
we suggest that they could be less toxic than the current anti-amebic
drugs, which have high toxicity in patients [7, 10, 11, 12, 13]. The low
toxicity of these compounds in patients would need veriﬁcation.
Several studies have reported antiparasitic effects of natural and
isolated/synthetic anthraquinones on diverse pathogenic unicellular
eukaryotes (Leishmania donovani, L. major, Plasmodium falciparum, Trypanosoma brucei), but the mechanism of action remains speculative [31,
32, 33, 34, 35, 36]. When interacting with the cellular chemistry of the
pathogen, these compounds seem to generate free oxygen metabolites
(which are toxic), alter DNA replication/repair enzymes, or cause direct
damage on the DNA [31, 32, 33, 34, 35, 36].
In Escherichia coli, rhein inhibits growth by targeting the AlkB DNA
repair enzyme; the inactive AlkB cannot ﬁx methyl lesions on the

The isolated/synthetic anthraquinones rhein, AHDDAC, unisol blue
AS, or sennoside B were effective at inhibiting amebic growth; they were
all equivalent to metronidazole when compared to the controls
(Figure 4). Rhein reached high inhibition values at 24 h, with little
change at 48 h for 60 μM or 120 μM concentrations (60 μM: 86.22%/
86.99%; 120 μM: 94.39%/95.53%; Table 2). Rhein IC50 value was 20.74
μM, better than those of the other three compounds (AHDDAC IC50 ¼
36.07 μM, unisol blue AS IC50 ¼ 33.59 μM, sennoside B IC50 ¼ 29.96 μM;
Table 2). The three compounds AHDDAC, unisol blue AS and sennoside B
showed noticeably higher inhibition at 120 μM concentration at 48 h
(90.65/84.55/92.28%; Table 2) than at 24 h (85.20/74.49/90.31%;
Table 2). Again, the rates of inhibition of the four compounds were
roughly comparable to those of metronidazole at 24 h or 48 h (Table 2).
And the IC50 was much lower for metronidazole than for the four compounds (Table 2), rationale above.
4. Discussion
As shown in this study (in vitro experiments), “rhein extract” from
Chinese rhubarb (R. palmatum) leaves and four isolated/synthetic anthraquinones (rhein, AHDDAC, unisol blue AS, and sennoside B) had
anti-amebic properties. Their inhibition effects on trophozoite growth
were comparable to the commercial drug metronidazole.
4
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our in vitro experiments) and/or prevent tissue/organ damage (based on
the commonality of the NF-κB pathway activation during kidney or liver
failure), but this needs further research.
We have previously shown that aggregations of Entamoeba spp.
secrete into the milieu signals associated with cell proliferation, cell
adhesion, cell movement, and stress-induced encystation (i.e. RasGap/
Ankyrin, coronin-WD40, actin, protein kinases, heat shock 70, and
ubiquitin [26, 41, 42]). Because encystation and abscess formation
require cell aggregation (i.e. abscesses are bound to cell recruitment), we
have postulated that disruption of E. histolytica capacity to group, via
silencing of alleles yet to be discovered, or drugs that alter the chemistry
of the recruitment signals secreted into the milieu, might be approaches
to mitigating amebiasis [26]. Thus, by combining current or novel
therapeutics (this paper) with the disruption of E. histolytica to aggregate,
we might ﬁnd new approaches to treatments [26, 41, 42].
5. Conclusion
Figure 3. Growth inhibition of E. histolytica trophozoites by Chinese rhubarb
(Rheum palmatum) extract (“rhein extract” as in Figure 1 top). A 100 μg/ml
concentration of “rhein extract”, as well as the exposure to the anti-amebic
metronidazole (20 μM), inhibited trophozoite growth at 24h and 48h (inoculum of 900-cells per plate well, 37  C incubation). Experiments were done in
triplicate (as shown in Figure 1 top). Controls contained TYI-S-33 media or TYIS-33 media þ DMSO (the latter used as solvent).

Chinese rhubarb leaves' “rhein extract” and the isolated/synthetic
anthraquinones rhein, AHDDAC, unisol blue AS and sennoside B inhibit
E. histolytica trophozoite growth in vitro. Their level of inhibition is
comparable to that of the commercial drug metronidazole. These compounds possibly act by generating toxic oxygen metabolites in the amebas, altering DNA replication/repair enzymes or directly damaging the
DNA. Because current amebiasis drugs are toxic to patients, generate
resistance in the pathogen, or can potentially induce cancer (as in has
been documented in animal models), alternative anti-amebic compounds
need to be discovered and tested to treat and manage amebiasis. Our
study suggests that anthraquinones might be such alternative
compounds.
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